Zobrazeno 1 - 10
of 9 573
pro vyhledávání: '"Schumacher, HR"'
Autor:
Torlakovic, Emina
Publikováno v:
In Modern Pathology 1 November 2000 13(11):1205-1205
Autor:
Jaap Fransen, Tuhina Neogi, T.L.Th.A. Jansen, Schumacher Hr, Nicola Dalbeth, William J. Taylor, Alexis Ogdie, Mark Weatherall
Publikováno v:
Europe PubMed Central
Annals of the Rheumatic Diseases, 74, 10, pp. 1868-74
Annals of the Rheumatic Diseases, 74, 1868-74
Annals of the Rheumatic Diseases, 74, 10, pp. 1868-74
Annals of the Rheumatic Diseases, 74, 1868-74
Item does not contain fulltext BACKGROUND: Although there has been major progress in gout imaging, no gout classification criteria currently include advanced imaging techniques. OBJECTIVE: To examine the usefulness of imaging modalities in the classi
Autor:
Viswanath, Vishalakshi1 (AUTHOR), Vishwanath, Tejas1 (AUTHOR) tejasvishwanath.igs@gmail.com, Joshi, Pradnya1 (AUTHOR), Lawate, Prakash1 (AUTHOR), Azhar, Shameela1 (AUTHOR)
Publikováno v:
Dermatologic Therapy. Nov/Dec2020, Vol. 33 Issue 6, p1-5. 5p.
Autor:
Dumusc, Alexandre, So, Alexander
Publikováno v:
Therapeutische Umschau; sep2024, Vol. 81 Issue 5, p168-171, 4p
Autor:
Michele Paessler, Schumacher Hr, Manas K. Akmatov, Liang Dai, X. Yu, Frank Pessler, Jialiang Li, Alexis Ogdie, Cesar Diaz-Torne
Publikováno v:
BIOMARKERS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Politècnica de Catalunya (UPC)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Politècnica de Catalunya (UPC)
Immunohistochemical synovial tissue biomarkers are used increasingly to classify arthropathies, study their pathogenesis, and to measure disease activity in clinical trials. We have used receiver operating characteristic (ROC) analysis to quantify th
Autor:
John S. Sundy, F Murphy, Scott Mellis, Stephanie Biedermann, Robert Terkeltaub, Richard Wu, S Bookbinder, Allen Radin, Schumacher Hr
Publikováno v:
Annals of the Rheumatic Diseases. 68:1613-1617
Recent studies suggest that blockade of the NLRP3 (cryopyrin) inflammasome interleukin 1beta (IL1beta) pathway may offer a new treatment strategy for gout.To explore the potential utility of rilonacept (IL1 Trap) in patients with chronic active gouty
Autor:
Seung-Hoon Baek1, Seungbae Oh2, Bum-Jin Shim3, Jeong Joon Yoo4, Jung-Mo Hwang5, Tae-Young Kim6 syty-chan@hanmail.net, Seung-Cheol Shim7 shimsc@cnuh.co.kr
Publikováno v:
Hip & Pelvis. Dec2024, Vol. 36 Issue 4, p234-249. 16p.
Autor:
Cheng, Xiaoyu1,2,3 (AUTHOR), Yan, Fei2,3 (AUTHOR), Xiaomei, Xue2,3 (AUTHOR), He, Qin1 (AUTHOR), Liu, Tian2,3 (AUTHOR), Ma, Lidan2,3 (AUTHOR), Dong, Ming1 (AUTHOR) dr_dongming@email.sdu.edu.cn
Publikováno v:
Thrombosis Journal. 11/26/2024, Vol. 22 Issue 1, p1-12. 12p.
Publikováno v:
Journal of Applied Sports Sciences - Arabic. Nov2024, Vol. 10 Issue 122, Part 2, p1-23. 19p.
Autor:
Zhang, Lei1,2 (AUTHOR), Zhang, Xinyi3 (AUTHOR), Pang, Long4,5 (AUTHOR), Wang, Zhuo1,2 (AUTHOR), Jiang, Junliang1,2 (AUTHOR) jjlhxkf@scu.edu.cn
Publikováno v:
Orthopaedic Surgery. Nov2024, Vol. 16 Issue 11, p2598-2607. 10p.